Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 131607, 9 pages
http://dx.doi.org/10.1155/2014/131607
Research Article

Characterisation of Potential Antidiabetic-Related Proteins from Pleurotus pulmonarius (Fr.) Quél. (Grey Oyster Mushroom) by MALDI-TOF/TOF Mass Spectrometry

1Mushroom Research Centre, Institute of Biological Sciences, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
2University of Malaya Centre for Proteomics Research, University of Malaya, 50603 Kuala Lumpur, Malaysia

Received 9 February 2014; Revised 4 June 2014; Accepted 22 July 2014; Published 28 August 2014

Academic Editor: Vittorio Calabrese

Copyright © 2014 Nurul Azwa Abd. Wahab et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Li, Z. Wang, X. Ying et al., “Garlic for diabetes mellitus,” Cochrane Database of Systematic Reviews, no. 7, Article ID CD009981, 2012. View at Google Scholar
  2. C. Sanz, J.-F.. Gautier, and H. Hanaire, “Physical exercise for the prevention and treatment of type 2 diabetes,” Diabetes and Metabolism, vol. 36, no. 5, pp. 346–351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Maggi, M. Noale, A. Pilotto, A. Tiengo, P. Cavallo Perin, and G. Crepaldi, “The Metabolic Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment,” Diabetes and Metabolism, vol. 39, no. 3, pp. 236–243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Hussain, B. Claussen, A. Ramachandran, and R. Williams, “Prevention of type 2 diabetes: a review,” Diabetes Research and Clinical Practice, vol. 76, no. 3, pp. 317–326, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Genuth, K. G. Alberti, P. Bennett et al., “Follow-up report on the diagnosis of diabetes mellitus,” Diabetes Care, vol. 26, no. 11, pp. 3160–3167, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. I. Ortiz, H. A. Ponce-Monter, E. Fernández-Martínez et al., “Pharmacological interaction between gabapentin and glibenclamide in the formalin test in the diabetic rat,” Proceedings of the Western Pharmacology Society, vol. 53, pp. 49–51, 2010. View at Google Scholar
  7. S. K. Singh, P. K. Rai, D. Jaiswal, and G. Watal, “Evidence-based critical evaluation of glycemic potential of Cynodon dactylon,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 4, pp. 415–420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Malviya, S. Jain, and S. Malviya, “Antidiabetic potential of medicinal plants,” Acta Poloniae Pharmaceutica, vol. 67, no. 2, pp. 113–118, 2010. View at Google Scholar · View at Scopus
  9. U. Etxeberria, A. L. de La Garza, J. Campin, J. A. Martnez, and F. I. Milagro, “Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase,” Expert Opinion on Therapeutic Targets, vol. 16, no. 3, pp. 269–297, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Aebersold and M. Mann, “Mass spectrometry-based proteomics,” Nature, vol. 422, no. 6928, pp. 198–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. T. B. Ng, “Peptides and proteins from fungi,” Peptides, vol. 25, no. 6, pp. 1055–1073, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Chen, B. Zhang, and P. C. K. Cheung, “Comparative proteomic analysis of mushroom cell wall proteins among the different developmental stages of Pleurotus tuber-regium,” Journal of Agricultural and Food Chemistry, vol. 60, no. 24, pp. 6173–6182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Khan and M. Tania, “Nutritional and medicinal importance of Pleurotus mushrooms: an overview,” Food Reviews International, vol. 28, no. 3, pp. 313–329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. H. Tan and M. N. Wahab, “Extracellular enzyme production during anamorphic growth in the edible mushroom, Pleurotus sajor-caju,” World Journal of Microbiology and Biotechnology, vol. 13, no. 6, pp. 613–617, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. R. P. Agrawal, A. Chopra, G. S. Lavekar et al., “Effect of oyster mushroom on glycemia, lipid profile and quality of life in type 2 diabetic patients,” Australian Journal of Medical Herbalism, vol. 22, no. 2, pp. 50–54, 2010. View at Google Scholar · View at Scopus
  16. M. Pramanik, S. Mondal, I. Chakraborty, D. Rout, and S. S. Islam, “Structural investigation of a polysaccharide (Fr. II) isolated from the aqueous extract of an edible mushroom, Pleurotus sajor-caju,” Carbohydrate Research, vol. 340, no. 4, pp. 629–636, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S. T. Chang and P. G. Miles, Mushrooms; Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact, CRC Press, New York, NY, USA, 2004.
  18. C. Ying, Y. Wang, and H. Tang, “Fungi—medicine—Chinese—identification—therapeutic use—pictorial works—China,” in Icons of Medicinal Fungi from China, pp. 572–575, 1987. View at Google Scholar
  19. E. Apostolidis, Y. I. Kwon, and K. Shetty, “Potential of cranberry-based herbal synergies for diabetes and hypertension management,” Asia Pacific Journal of Clinical Nutrition, vol. 15, no. 3, pp. 433–441, 2006. View at Google Scholar · View at Scopus
  20. E. Apostolidis, Y.-I. Kwon, and K. Shetty, “Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension,” Innovative Food Science & Emerging Technologies, vol. 8, no. 1, pp. 46–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. U. Laemmli, “SDS-PAGE to evaluate extent of hydrolysis, of proteins,” Nature, vol. 227, no. 5259, pp. 680–685, 1976. View at Google Scholar
  22. R. A. Codario, “Oral agents for type-2 diabetes,” in Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome, Current Clinical Practice, pp. 93–122, Humana Press, 2011. View at Publisher · View at Google Scholar
  23. G. Kanagasabapathy, S. N. A. Malek, A. A. Mahmood, K. H. Chua, S. Vikineswary, and U. R. Kuppusamy, “Beta-glucan-rich extract from Pleurotus sajor-caju (Fr.) singer prevents obesity and oxidative stress in C57BL/6J mice fed on a high-fat diet,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 185259, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. R. K. Scopes, Protein Purification: Principles and Practice, Springer, New York, NY, USA, 3rd edition, 1994.
  25. N. Seedher and M. Kanojia, “Reversible binding of antidiabetic drugs, repaglinide and gliclazide, with human serum albumin,” Chemical Biology and Drug Design, vol. 72, no. 4, pp. 290–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Melander, “Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes: brief overview,” Diabetes, vol. 53, supplemement 3, pp. S151–S155, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Gruzman, G. Babai, S. Sasson et al., “Erratum to: adenosine monophosphate-activated protein kinase (AMPK) as a new target for antidiabetic drugs: a review on metabolic, pharmacological and chemical considerations by gruzman et al., rev diabet stud 2009, 6 (1): 13–36,” The Review of Diabetic Studies: RDS, vol. 6, no. 2, article 130, 2009. View at Google Scholar
  28. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli, “Cellular and molecular mechanisms of metformin: an overview,” Clinical Science, vol. 122, no. 6, pp. 253–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. N. G. Oikonomakos, S. E. Zographos, V. T. Skamnaki, and G. Archontis, “The 1.76 Å resolution crystal structure of glycogen phosphorylase B complexed with glucose, and CP320626, a potential antidiabetic drug,” Bioorganic & Medicinal Chemistry, vol. 10, no. 5, pp. 1313–1319, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. K. H. Thompson and C. Orvig, “Vanadium in diabetes: 100 years from Phase 0 to Phase I,” Journal of Inorganic Biochemistry, vol. 100, no. 12, pp. 1925–1935, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Vidali, R. C. Augustine, K. P. Kleinman, and M. Bezanilla, “Profilin is essential for tip growth in the moss Physcomitrella patens,” The Plant Cell, vol. 19, no. 11, pp. 3705–3722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Y. Chu and R. L. Silverstein, “CD36 ectodomain phosphorylation blocks thrombospondin-1 binding structure-function relationships and regulation by protein kinase C,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 3, pp. 760–767, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Geraldes and G. L. King, “Activation of protein kinase C isoforms and its impact on diabetic complications,” Circulation Research, vol. 106, no. 8, pp. 1319–1331, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Piconi, M. A. Ihnat, and A. Ceriello, “Oxidative stress in the pathogenesis/treament of diabetes and its complications,” Current Nutrition and Food Science, vol. 3, no. 3, pp. 194–199, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. T. Elnakish and H. H. Hassanain, “Profilin, and vascular diseases,” in Biochemistry, pp. 65–106, InTech, Rijeka, Croatia, 2012. View at Google Scholar
  36. J. Menne, M. Meier, J. Park, and H. Haller, “Inhibition of protein kinase C in diabetic nephropathy—where do we stand?” Nephrology Dialysis Transplantation, vol. 24, no. 7, pp. 2021–2023, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Skvortsova, “Profilin 1: do we have a novel proteome-found biomarker predicting response to anticancer therapy?” Proteomics, vol. 13, no. 14, pp. 2069–2071, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. D. L. V. Jagt, “Methylglyoxal, diabetes mellitus and diabetic complications,” Drug Metabolism and Drug Interactions, vol. 23, no. 1-2, pp. 93–124, 2008. View at Google Scholar · View at Scopus
  39. S. Madsen-Bouterse, G. Mohammad, and R. A. Kowluru, “Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 51, no. 3, pp. 1765–1772, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Maher, “Methylglyoxal, advanced glycation end products and autism: is there a connection?” Medical Hypotheses, vol. 78, no. 4, pp. 548–552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. P. J. Beisswenger, S. K. Howell, K. Smith, and B. S. Szwergold, “Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes,” Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1637, no. 1, pp. 98–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. A. D. Elbein, Y. T. Pan, I. Pastuszak, and D. Carroll, “New insights on trehalose: a multifunctional molecule,” Glycobiology, vol. 13, no. 4, pp. 17R–27R, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Eis and B. Nidetzky, “Characterization of trehalose phosphorylase from Schizophyllum commune,” Biochemical Journal, vol. 341, no. 2, pp. 385–393, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Arai, M. Kohguchi, S. Akamatsu et al., “Trehalose suppresses lipopolysaccharide-induced osteoclastogenesis bone marrow in mice,” Nutrition Research, vol. 21, no. 7, pp. 993–999, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Arai, N. Arai, A. Mizote et al., “Trehalose prevents adipocyte hypertrophy and mitigates insulin resistance,” Nutrition Research, vol. 30, no. 12, pp. 840–848, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Pan, J. D. Carroll, N. Asano, I. Pastuszak, V. K. Edavana, and A. D. Elbein, “Trehalose synthase converts glycogen to trehalose,” Federation of European Biochemical Societies Journal, vol. 275, no. 13, pp. 3408–3420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Wolf, R. Krämer, and S. Morbach, “Three pathways for trehalose metabolism in Corynebacterium glutamicum ATCC13032 and their significance in response to osmotic stress,” Molecular Microbiology, vol. 49, no. 4, pp. 1119–1134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Góth and W. N. Bigler, “Blood catalase deficiency and diabetes in Hungary,” Diabetes Care, vol. 24, no. 10, pp. 1839–1840, 2001. View at Google Scholar · View at Scopus
  50. J. Styskal, H. van Remmen, A. Richardson, and A. B. Salmon, “Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models?” Free Radical Biology and Medicine, vol. 52, no. 1, pp. 46–58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Góth and T. Nagy, “Acatalasemia and diabetes mellitus,” Archives of Biochemistry and Biophysics, vol. 525, no. 2, pp. 195–200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Prentki and C. J. Nolan, “Islet β cell failure in type 2 diabetes,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1802–1812, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. J. W. Baynes and S. R. Thorpe, “Role of oxidative stress in diabetic complications: a new perspective on an old paradigm,” Diabetes, vol. 48, no. 1, pp. 1–9, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. S. B. Bankar, M. V. Bule, R. S. Singhal, and L. Ananthanarayan, “Optimization of Aspergillus niger fermentation for the production of glucose oxidase,” Food and Bioprocess Technology, vol. 2, no. 4, pp. 344–352, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. K. R. Messner and J. A. Imlay, “Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase,” The Journal of Biological Chemistry, vol. 277, no. 45, pp. 42563–42571, 2002. View at Publisher · View at Google Scholar · View at Scopus